Gary Patou - Director at Xenon Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
XENE on Nasdaq
All Insider Reports
All Insider Reports

Gary Patou - trading volume in the past year for Xenon Pharmaceuticals Inc.

Holdings reported by Gary Patou for Xenon Pharmaceuticals Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 23.6K $232K $9.85 Dec 13, 2023 Direct
Common Shares 4.9K $48.3K $9.85 Dec 14, 2023 Indirect
Stock Option (Right to Buy) 15.5K Jun 5, 2024 Direct Common Shares

Transactions reported by Gary Patou for Xenon Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.